Replay available

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call

TELA Bio, Inc. (NASDAQ: TELA) Q2 2026 earnings conference call, held 2026-08-10. Replay captured from the company's public earnings webcast.

Mon, August 10, 2026 at 4:30 PMendedReplay
TELA Bio, Inc. (TELA) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Louisa Smith

Investor Relations

Joe Capper

Chairman of the Board

Heather Goetz

Chief Executive Officer

Jeff Blizzard

President

Roberto Cuca

Chief Operating Officer and Chief Financial Officer

Jim Hagen

Senior Vice President of Strategic Operations and Marketing

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the TeleBio second quarter 2026 earnings conference call. At this time, all participants are in listen-only mode. Following the prepared remarks, there'll be a question and answer session. Please be advised that today's conference is being recorded. I will now like to turn the conference over to Louisa Smith. Thank you, Lisa, and good afternoon, everyone. Earlier today, Tela Bio released financial results for the second quarter and to June 30th, 2026. A copy of the press release is available on the company's website. Joining me on today's call are Joe Capper, Chairman of the Board, Heather Goetz, Chief Executive Officer, Jeff Blizzard, President, Roberto Cuca, Chief Operating Officer and Chief Financial Officer, and Jim Hagen, Senior Vice President of Strategic Operations and Marketing. Before we begin, I'd like to remind you that during this conference call, the company may make projections and forward-looking statements regarding future events. We encourage you to review the company's past and future filings with the SEC, including, without limitation, the company's quarterly reports on Forms 10Q, which identify the specific risk factors that may cause actual results or events to differ materially from those described in these forward-looking statements. These factors may include, without limitation, regarding product development, pipeline opportunities, sales and marketing strategies, and the impact of various additional risk factors as identified in our regulatory filings. With that, I'll now turn the call over to Joe. Thank you, Louisa. Good afternoon, and thank you for joining Telebio's second quarter 2026 earnings call. I will start the call with a few comments about the important leadership change announced...

More from Tela Bio, Inc.